Ganoderic Acid A Alleviates OVA-Induced Asthma in Mice [PDF]
AbstractThe aim of this study is to investigate the effects of ganoderic acid A (GAA) on OVA-induced asthma in mice. Mouse asthma model was established by ovalbumin (OVA) in vitro. Diff-Quik staining was used to observe the total numbers of cells and the number of classification cells in each group, and HE staining was used to observe lung inflammation
Xinhua Lu +3 more
openaire +2 more sources
Ganoderic Acid A Metabolites and Their Metabolic Kinetics [PDF]
Ganoderic acid A (GAA), a representative active triterpenoid from Ganoderma lucidum, has been reported to exhibit antinociceptive, antioxidative, cytotoxic, hepatoprotective and anticancer activities. The present study aims (1) to identify GAA metabolites, in vivo by analyzing the bile, plasma and urine after intravenous administration to rats (20 mg ...
Cao, Fang-Rui +6 more
openaire +2 more sources
The Potential Alleviating Property Against NAFLD by <i>Ganoderma lucidum</i> With Bacteria-Enzyme Synergistic Fermentation. [PDF]
A bacteria‐enzyme synergistic fermentation process using Lactobacillus rhamnosus was developed to produce fermented Ganoderma lucidum broth (FBG), which significantly enriched ganoderic acid F compared to water extraction. In FFA‐induced HepG2 cells, FBG alleviated NAFLD‐related damage by reducing lipid deposition, ROS, MDA, TC, TG, and LDL‐C, while ...
Sun M +6 more
europepmc +2 more sources
Biotransformation of Ganoderic Acid A to 3-O-Acetyl Ganoderic Acid A by Soil-isolated Streptomyces sp. [PDF]
The medicinal fungus Ganoderma lucidum contains many bioactive triterpenoids, ganoderic acid A (GAA) being one of the major ones. The present study explored the microbial biotransformation of GAA, isolating 283 strains of soil actinomycetes and determining their abilities to biotransform GAA with ultra-performance liquid chromatography analysis.
Te-Sheng Chang +4 more
openaire +2 more sources
Ganoderic Acid A Ameliorates Pentylenetetrazol-Induced Epilepsy in Mice via Activating KCNQ2. [PDF]
GA‐A binds and activates KCNQ2, thereby reducing epileptic‐like EEG discharges, the loss and apoptosis of hippocampal neurons, and improving anxiety and depression‐like behavioral changes. In addition, GA‐A inhibits neuroinflammation and alleviates oxidative stress independent of activating KCNQ2.
Yao Y +5 more
europepmc +2 more sources
Target identification of HIV related ganoderic acids using molecular docking / Rahmad Akbar [PDF]
Four Ganoderic acids (á, B, C1 H) were studied using molecular docking approach. Both reverse molecular docking and molecular docking were combined to elucidate suitable target(s) for these Ganoderic acids. Outcomes from molecular docking were compared
Akbar, Rahmad
core +2 more sources
A Triterpenoid-Enriched GLE70 Fraction From <i>Ganoderma lingzhi</i> Ameliorates Alcoholic Liver Disease via Multi-Target Regulation. [PDF]
GLE fractions were prepared from Ganoderma lingzhi using gradient ethanol elution and evaluated for their biological activities. Among the fractions, GLE70 exhibited the strongest antioxidant and hepatoprotective effects. Integrated chemical characterization, network pharmacology, molecular docking, and in vivo validation suggested that GLE70 may exert
Chen Y +7 more
europepmc +2 more sources
Data_Sheet_1_A methyltransferase LaeA regulates ganoderic acid biosynthesis in Ganoderma lingzhi.PDF
The methyltransferase LaeA is a global regulator involved in the biosynthesis of secondary metabolites by ascomycete fungi. However, little is known of its regulatory role in basidiomycete fungi.
Na Li (6550) +2 more
core +1 more source
The genus Ganoderma has been little studied in arid areas worldwide. Ganoderma subincrustatum and Ganoderma weberianum strains were obtained from the Sonoran Desert, Sonora, Mexico. Ganoderma spp.
Damian López-Peña +5 more
doaj +1 more source
Ganoderic Acid in the Treatment of Prostate Cancer [PDF]
Prostate cancer is the most commonly diagnosed cancer in men and is the second most common cause of cancer-related deaths in the western world. Presently, the most common options for treatment are prostatectomy, radiation and chemotherapy. While certain immunotherapeutics have shown promise in clinical trials, the search for more effective, long-term ...
openaire +2 more sources

